NeurAxis, Inc. (NRXS) Stock

Healthcare · Biotechnology · Member of Other US Stocks

NeurAxis, Inc. (NRXS) closed at USD 6.53 on 2026-10-14, a change of +116.2 % over the past year, with a market capitalization of USD 97.2M.

NeurAxis, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

NeurAxis, Inc. key figures

Previous close

USD 6.53 (2026-10-14)

1-year change

+116.2 %

Market cap

USD 97.2M

Enterprise value

USD 89.16M

P/E ratio (trailing)

-8.32

P/E ratio (forward)

-28.67

EPS (trailing)

-0.93

EPS (forward)

-0.27

PEG ratio

n/a

Price to book

14.33

Revenue growth

115.7 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

2.45

Employees

24

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About NeurAxis, Inc.

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and associated FD nausea symptoms. The company also offers rectal expulsion device, a screening tool that helps to detects evacuation disorders. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. NeurAxis, Inc. was founded in 2011 and is headquartered in Carmel, Indiana.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for NeurAxis, Inc. and compare it with other stocks.